Abstract: This invention provides a method to enhance an immune response of nucleic acid vaccination by simultaneous administration of a polynucleotide and a polypeptide of interest.
Type:
Grant
Filed:
June 12, 2000
Date of Patent:
December 31, 2002
Assignee:
SmithKline Beecham Biologicals, S.A.
Inventors:
Wilfried Dalemans, Marcelle Van Mechelen, Claudine Bruck, Martin Friede